Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 24;2013(10):CD009104.
doi: 10.1002/14651858.CD009104.pub2.

Dietary supplements for preventing postnatal depression

Brendan J Miller  1 , Linda Murray, Michael M Beckmann, Terrence Kent, Bonnie Macfarlane
Affiliations

Dietary supplements for preventing postnatal depression

Brendan J Miller et al. Cochrane Database Syst Rev. .

Abstract

Background: Postnatal depression is a medical condition that affects many women and the development of their infants. There is a lack of evidence for treatment and prevention strategies that are safe for mothers and infants. Certain dietary deficiencies in a pregnant or postnatal woman's diet may cause postnatal depression. By correcting these deficiencies postnatal depression could be prevented in some women. Specific examples of dietary supplements aimed at preventing postnatal depression include: omega-3 fatty acids, iron, folate, s-adenosyl-L-methionine, cobalamin, pyridoxine, riboflavin, vitamin D and calcium.

Objectives: To assess the benefits of dietary supplements for preventing postnatal depression either in the antenatal period, postnatal period, or both.

Search methods: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 April 2013).

Selection criteria: Randomised controlled trials, involving women who were pregnant or who had given birth in the previous six weeks, who were not depressed or taking antidepressants at the commencement of the trials. The trials could use as intervention any dietary supplementation alone or in combination with another treatment compared with any other preventive treatment, or placebo, or standard clinical care.

Data collection and analysis: Two review authors independently assessed trials for inclusion and assessed the risk of bias for the two included studies. Two review authors extracted data and the data were checked for accuracy.

Main results: We included two randomised controlled trials.One trial compared oral 100 microgram (µg) selenium yeast tablets with placebo, taken from the first trimester until birth. The trial randomised 179 women but outcome data were only provided for 85 women. Eighty-three women were randomised to each arm of the trial. Sixty-one women completed the selenium arm, 44 of whom completed an Edinburgh Postnatal Depression Scale (EPDS). In the placebo arm, 64 women completed the trial, 41 of whom completed an EPDS. This included study (n = 85) found selenium had an effect on EPDS scores but did not reach statistical significance (P = 0.07). There was a mean difference (MD) of -1.90 (95% confidence interval (CI) -3.92 to 0.12) of the self-reported EPDS completed by participants within eight weeks of delivery. There was a high risk of attrition bias due to a large proportion of women withdrawing from the study or not completing an EPDS. This included study did not report on any of the secondary outcomes of this review.The other trial compared docosahexanoic acid (DHA) and eicosapentaenoic acid (EPA) with placebo. The trial randomised 126 women at risk of postpartum depression to three arms: 42 were allocated to EPA, 42 to DHA, and 42 to placebo. Three women in the EPA arm, four in the DHA arm, and one woman in the placebo arm were lost to follow-up. Women who were found to have major depressive disorder, bipolar disorder, current substance abuse or dependence, suicidal ideation or schizophrenia at recruitment were excluded from the study. The women who discontinued the intervention (five in the EPA arm, four in the DHA arm and seven in the placebo arm) were included in the intention-to-treat analysis, while those who were lost to follow-up were not. Women received supplements or placebo from recruitment at a gestational age of 12 to 20 weeks until their final review visit six to eight weeks postpartum. The primary outcome measure was the Beck Depression Inventory (BDI) score at the fifth visit (six to eight weeks postpartum). No benefit was found for EPA-rich fish oil (MD 0.70, 95% CI -1.78 to 3.18) or DHA-rich fish oil supplementation (MD 0.90, 95% CI -1.33 to 3.13) in preventing postpartum depression. No difference was found in the effect on postnatal depression comparing EPA with DHA (MD -0.20, 95% CI -2.61 to 2.21). No benefit or significant effect was found in terms of the secondary outcomes of the presence of major depressive disorder at six to eight weeks postpartum, the number of women who commenced antidepressants, maternal estimated blood loss at delivery or admission of neonates to the neonatal intensive care unit.

Authors' conclusions: There is insufficient evidence to conclude that selenium, DHA or EPA prevent postnatal depression. There is currently no evidence to recommend any other dietary supplement for prevention of postnatal depression.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Study flow diagram.
1.1
1.1. Analysis
Comparison 1 Selenium versus placebo, Outcome 1 EPDS score.
2.1
2.1. Analysis
Comparison 2 EPA versus placebo, Outcome 1 Beck Depression Inventory Score.
2.2
2.2. Analysis
Comparison 2 EPA versus placebo, Outcome 2 Presence of Major Depressive Disorder.
2.3
2.3. Analysis
Comparison 2 EPA versus placebo, Outcome 3 Started antidepressant.
2.4
2.4. Analysis
Comparison 2 EPA versus placebo, Outcome 4 Maternal estimated blood loss (ml).
2.5
2.5. Analysis
Comparison 2 EPA versus placebo, Outcome 5 NICU admission of neonate.
3.1
3.1. Analysis
Comparison 3 DHA versus placebo, Outcome 1 Beck Depression Inventory Score.
3.2
3.2. Analysis
Comparison 3 DHA versus placebo, Outcome 2 Presence of Major Depressive Disorder.
3.3
3.3. Analysis
Comparison 3 DHA versus placebo, Outcome 3 Started antidepressant.
3.4
3.4. Analysis
Comparison 3 DHA versus placebo, Outcome 4 Maternal estimated blood loss (ml).
3.5
3.5. Analysis
Comparison 3 DHA versus placebo, Outcome 5 NICU admission of neonate.
4.1
4.1. Analysis
Comparison 4 EPA versus DHA, Outcome 1 Beck Depression Inventory Score.
4.2
4.2. Analysis
Comparison 4 EPA versus DHA, Outcome 2 Presence of Major Depressive Disorder.
4.3
4.3. Analysis
Comparison 4 EPA versus DHA, Outcome 3 Started antidepressant.
4.4
4.4. Analysis
Comparison 4 EPA versus DHA, Outcome 4 Maternal estimated blood loss (ml).
4.5
4.5. Analysis
Comparison 4 EPA versus DHA, Outcome 5 NICU admission of neonate.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD009104

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Mokhber 2011 {published data only}
    1. Mokhber N, Namjoo M, Tara F, Boskabadi H, Rayman MP, Ghayour‐Mobarhan M, et al. Effect of supplementation with selenium on postpartum depression: a randomized double‐blind placebo‐controlled trial. Journal of Maternal‐Fetal and Neonatal Medicine 2011;24(1):104‐8. - PubMed
Mozurkewich 2013 {published data only}
    1. Mozurkewich E, Chilimigras J, Klemens C, Keeton K, Allbaugh L, Hamilton S, et al. The mothers, Omega‐3 and mental health study protocol. BMC Pregnancy and Childbirth 2011;11:46. - PMC - PubMed
    1. Mozurkewich E, Clinton C, Chilimigras J, Hamilton S, Allbaugh L, Berman D, et al. The Mothers, Omega‐3 & Mental Health Study: a double‐blind, randomized controlled trial. American Journal of Obstetrics and Gynecology 2013;208(1 Suppl):S19‐S20. - PMC - PubMed
    1. Mozurkewich EL, Clinton CM, Chilimigras JL, Hamilton SE, Allbaugh LJ, Berman DR, et al. The Mothers, Omega‐3, and Mental Health Study: a double‐blind, randomized controlled trial. American Journal of Obstetrics and Gynecology 2013;208(4):313.e1‐313.e9. - PMC - PubMed
    1. Romero V, Stolberg V, Chensue S, Clinton C, Djuric Z, Berman D, et al. Developmental programming for allergic disease: a secondary analysis of the Mothers, Omega‐3 and Mental Health Study. American Journal of Obstetrics and Gynecology 2013;208(1 Suppl):S24. - PMC - PubMed
    1. Romero VC, Somers EC, Stolberg V, Clinton C, Chensue S, Djuric Z, et al. Developmental programming for allergy: a secondary analysis of the Mothers, Omega‐3, and Mental Health Study. American Journal of Obstetrics and Gynecology 2013;208(4):316.e1‐e.6. - PMC - PubMed

References to studies excluded from this review

Beard 2005 {published data only}
    1. Beard JL, Hendricks MK, Perez EM, Murray‐Kolb LE, Berg A, Vernon‐Feagans L, et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. Journal of Nutrition 2005;135(2):267‐72. - PubMed
Doornbos 2009 {published data only}
    1. Doornbos B, Goor SA, Dijck‐Brouwer DA, Schaafsma A, Korf J, Muskiet FA. Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Progress in Neuro‐Psychopharmacology & Biological Psychiatry 2009;33(1):49‐52. - PubMed
Dunstan 2003 {published data only}
    1. Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Immunology 2003;112(6):1178‐84. - PubMed
    1. Mattes E, McCarthy S, Gong G, Eekelen JA, Dunstan J, Foster J, et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, & Immunity 2009;23(3):380‐8. - PubMed
Freeman 2004 {published data only}
    1. Freeman MP, Hibbeln J, Wisner K, Watchman M, Brumbach B, Hill R, et al. Double‐blind dose‐finding study of omega‐3 fatty acids for postpartum depression. Neuropsychopharmacology 2004;29(Suppl 1):S102.
Freeman 2006 {published data only}
    1. Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ. Randomized dose‐ranging pilot trial of omega‐3 fatty acids for postpartum depression. Acta Psychiatrica Scandinavica 2006;113(1):31‐5. - PubMed
Freeman 2007 {published data only}
    1. Freeman MP, Sinha P. Tolerability of omega‐3 fatty acid supplements in perinatal women. Prostaglandins Leukotrienes & Essential Fatty Acids 2007;77(3‐4):203‐8. - PubMed
Freeman 2008 {published data only}
    1. Freeman MP, Davis M, Sinha P, Wisner KL, Hibbeln JR, Gelenberg AJ. Omega‐3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo‐controlled study. Journal of Affective Disorders 2008;110(1‐2):142‐8. - PMC - PubMed
Freeman 2010 {published data only}
    1. Freeman MP, Davis MF. Supportive psychotherapy for perinatal depression: preliminary data for adherence and response. Depression and Anxiety 2010;27(1):39‐45. - PubMed
Harrison‐Hohner 2001 {published data only}
    1. Harrison‐Hohner J, Coste S, Dorato V, Curet LB, McCarron D, Hatton D. Prenatal calcium supplementation and postpartum depression: an ancillary study to a randomized trial of calcium for prevention of preeclampsia. Archives of Womens Mental Health 2001;3:141‐6.
Llorente 2003 {published data only}
    1. Llorente AM, Jensen CL, Voigt RG, Fraley JK, Berretta MC, Heird WC. Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. American Journal of Obstetrics and Gynecology 2003;188(5):1348‐53. - PubMed
Makrides 2010 {published data only}
    1. Makrides M. A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) (accessed 6 December 2005).
    1. Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J, Ryan P, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010;304(15):1675‐83. - PubMed
Rees 2008 {published data only}
    1. Rees AM, Austin MP, Parker GB. Omega‐3 fatty acids as a treatment for perinatal depression: randomized double‐blind placebo‐controlled trial. Australian and New Zealand Journal of Psychiatry 2008;42(3):199‐205. - PubMed
Smith 2007 {published data only}
    1. Smith Fawzi MC, Kaaya SF, Mbwambo J, Msamanga GI, Antelman G, Wei R, et al. Multivitamin supplementation in HIV‐positive pregnant women: impact on depression and quality of life in a resource‐poor setting. HIV Medicine 2007;8(4):203‐12. - PMC - PubMed
Su 2008 {published data only}
    1. Su KP, Huang SY, Chiu TH, Huang KC, Huang CL, Chang HC, et al. Omega‐3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double‐blind, placebo‐controlled trial. Journal of Clinical Psychiatry 2008;69(4):644‐51. - PubMed

References to studies awaiting assessment

Judge 2011 {published data only}
    1. Judge MP, Beck CT, Durham H, Mckelvey MM, Lammi‐Keefe CJ. Maternal docosahexaenoic acid (DHA, 22:6n‐3) consumption during pregnancy decreases postpartum depression (PPD) symptomatology. FASEB Journal 2011;25:349.7.

Additional references

Adewuya 2008
    1. Adewuya AO, Ola BO, Aloba OO, Mapayi BM, Okeniyi JA. Impact of postnatal depression on infants' growth in Nigeria. Journal of Affective Disorders 2008;108(1‐2):191‐3. - PubMed
Affonso 2000
    1. Affonso DD, Anindya KD, Horowitz JA, Mayberry, LJ. An international study exploring levels of postpartum depressive symptomatology. Journal of Psychosomatic Research 2000;49(3):207‐16. - PubMed
Albacar 2011
    1. Albacar G, Sans T, Martin‐Santos R, Garcia‐Esteve L, Guillamat R, Sanjuan J, et al. An association between plasma ferritin concentrations measured 48h after delivery and postpartum depression. Journal of Affective Disorders 2011;131(1):136‐42. - PubMed
APA 2000
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Text Revision (DSM‐IV‐TR). 4th Edition. Washington, DC: American Psychiatric Association, 2000.
Austin 2008
    1. Austin MP, Priest SR, Sullivan EA. Antenatal psychosocial assessment for reducing perinatal mental health morbidity. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD005124.pub2] - DOI - PMC - PubMed
Azaïs‐Braesco 2000
    1. Azaïs‐Braesco V, Pascal G. Vitamin A in pregnancy: requirements and safety limits. American Journal of Clinical Nutrition 2000;71(5):1325S‐1333S. - PubMed
Beck 1961
    1. Beck AT, Ward C, Mendelson M. An inventory for measuring depression. Archives of General Psychiatry 1961;4:561‐71. - PubMed
Beck 1999
    1. Beck CT. Maternal depression and child behaviour problems: a meta‐analysis. Journal of Advanced Nursing 1999;29(3):623‐9. - PubMed
Beck 2006
    1. Beck CT, Driscoll JW. Postpartum Mood and Anxiety Disorders: a Clinician's Guide. Sudbury, MA: Jones and Bartlett Publishers, 2006.
Boyce 1994
    1. Boyce P. Personality dysfunction, marital problems, and postnatal depression. In: Cox J, Holden J editor(s). Perinatal Psychiatry: Use and Misuse of the Edinburgh Postnatal Depression Scale. London: Gaskell, 1994.
Breznitz 1988
    1. Breznitz Z, Friedman SL. Toddlers' concentration: does maternal depression make a difference?. Journal of Child Psychiatry & Psychiatry & Allied Disciplines 1988;29(3):267‐79. - PubMed
Brockington 1996
    1. Brockington IF. Motherhood and Mental Health. Oxford, UK: Oxford University Press, 1996.
Brockington 2004
    1. Brockington I. Diagnosis and management of post‐partum disorders: a review. World Psychiatry 2004;3(2):89‐95. - PMC - PubMed
Buist 1998
    1. Buist A. Child abuse, postpartum depression and parenting difficulties: a literature review of associations. Australian and New Zealand Journal of Psychiatry 1998;32:370‐8. - PubMed
Cooper 1995
    1. Cooper P, Murray L. The course and recurrence of postnatal depression. British Journal of Psychiatry 1995;166:191‐5. - PubMed
Cooper 1998
    1. Cooper P, Murray L. Postnatal depression. BMJ 1998;316:1884‐6. - PMC - PubMed
Corwin 2003
    1. Corwin E, Murray‐Kolb L, Beard J. Low hemoglobin level is a risk factor for postpartum depression. Journal of Nutrition 2003;133:4139‐42. - PubMed
Cox 1987
    1. Cox A, Puckering C, Pound A, Mills M. The impact of maternal depression in young children. Journal of Child Psychology & Psychiatry & Allied Disciplines 1987;28(6):917‐28. - PubMed
Cox 1987a
    1. Cox J, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10‐item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry 1987;150:782‐6. - PubMed
Cox 1993
    1. Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. British Journal of Psychiatry 1993;163:27‐31. - PubMed
Cox 2003
    1. Cox JL, Holden J. Perinatal Mental Health: a Guide to the Edinburgh Postnatal Depression Scale. London: RCPsych Publications, 2003.
Cummings 1994
    1. Cummings E, Davies P. Maternal depression and child development. Journal of Child Psychology & Psychiatry & Allied Disciplines 1994;35(1):73‐112. - PubMed
Dalton 1982
    1. Dalton K. Depression after childbirth. BMJ 1982;284:1331‐2. - PMC - PubMed
Deave 2008
    1. Deave T, Heron J, Evans J, Emond A. The impact of maternal depression in pregnancy on early child development. BJOG: an international journal of obstetrics and gynaecology 2008;115(8):1043‐51. - PubMed
Dennis 2004
    1. Dennis CL, Creedy DK. Psychosocial and psychological interventions for preventing postpartum depression. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD001134.pub2] - DOI - PubMed
Dennis 2006
    1. Dennis CL, Leinic CL. Postpartum depression help‐seeking barriers and maternal treatment preferences: a qualitative systematic review. Birth 2006;33(4):323‐31. - PubMed
Dennis 2007a
    1. Dennis CL, Hodnett ED. Psychosocial and psychological interventions for treating postpartum depression. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006116.pub2] - DOI - PubMed
Dennis 2007b
    1. Dennis CL, Ross LE, Grigoriadis S. Psychosocial and psychological interventions for treating antenatal depression. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD006309.pub2] - DOI - PubMed
Dennis 2008a
    1. Dennis CL, Ross LE, Herxheimer A. Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD001690.pub2] - DOI - PMC - PubMed
Dennis 2008b
    1. Dennis CL, Allen K. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD006795.pub2] - DOI - PubMed
Dennis 2009
    1. Dennis CL, Hodnett E, Kenton L, Weston J, Zupancic J, Stewart DE, et al. Effect of peer support on prevention of postnatal depression among high risk women: multisite randomised controlled trial. BMJ 2009;338:a3064. - PMC - PubMed
Fisher 2009
    1. Fisher J, Cabral de Mello M, Izutsu T. Contemporary Topics in Women's Mental Health. Singapore: Wiley‐Blackwell, 2009.
Fisher 2012
    1. Fisher J, Cabral de Mello M, Patel V, Rahman A, Tran T, Holton S, et al. Prevalence and determinants of common perinatal mental disorders in women in low‐ and lower‐middle‐income countries: a systematic review. Bulletin of the World Health Organization 2012;90(2):139G‐149G. - PMC - PubMed
Forman 2007
    1. Forman DR, O'Hara MW, Stuart S, Gorman LL, Larsen KE, Coy KC. Effective treatment for postpartum depression is not sufficient to improve the developing mother‐child relationship. Development and Psychopathology 2007;19(2):585‐602. - PubMed
Fortinguerra 2009
    1. Fortinguerra F, Clavenna A, Bonati M. Psychotropic drug use during breastfeeding: a review of the evidence. Paediatrics 2009;124(4):e547‐e556. - PubMed
Freeman 2009
    1. Freeman MP. Complementary and alternative medicine for perinatal depression. Journal of Affective Disorders 2009;112(1‐3):1‐10. - PubMed
Garcion 2002
    1. Garcion E, Wion‐Barbot N, Montero‐Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends in Endocrinology and Metabolism 2002;13(3):100‐5. - PubMed
Gibbon 2004
    1. Gibbon K. Developments in perinatal mental health assessments. British Journal of Midwifery 2004;12(12):754‐60.
Gibson 2009
    1. Gibson J, McKenzie‐McHarg K, Shakespeare J, Price J, Gray R. A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women. Acta Psychiatrica Scandinavica 2009;119(5):350‐64. - PubMed
Gjerdingen 2011
    1. Gjerdingen D, Crow S, McGovern P, Miner M, Center B. Changes in depressive symptoms over 0‐9 months postpartum. Journal of Women's Health 2011;20(3):381‐6. - PMC - PubMed
Hamilton 1960
    1. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960;23:56‐62. - PMC - PubMed
Hanley 2009
    1. Hanley J. Perinatal Mental Health. Singapore: Wiley‐Blackwell, 2009.
Harpham 2005
    1. Harpham T, Huttly S, Silva MJ, Abramsky T. Maternal mental health and child nutritional status in four developing countries. Journal of Epidemiology & Community Health 2005;59(12):1060‐4. - PMC - PubMed
Hibbeln 2002
    1. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross‐national, ecological analysis. Journal of Affective Disorders 2002;69:15‐29. - PubMed
Higgins 2011
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hipwell 2000
    1. Hipwell AE, Goossens FA, Melhuish EC, Kumar R. Severe maternal psychopathology and infant‐mother attachment. Developmental Psychopathology 2000;12(2):157‐75. - PubMed
Hoffbrand 2001
    1. Hoffbrand SE, Howard L, Crawley H. Antidepressant treatment for post‐natal depression. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD002018] - DOI - PubMed
Holden 1991
    1. Holden JM. Postnatal depression: its nature, effects and identification using the Edinburgh postnatal depression scale. Birth 1991;18(4):211‐21. - PubMed
Hoogendijk 2008
    1. Hoogendijk W, Lips P, Dik MG, Deeg D, Beekman A, Penninx B. Depression is associated with decreased 25‐hydroxyvitamin D and increased parathyroid hormone levels in older adults. Archives of General Psychiatry 2008;65(5):508‐12. - PubMed
Howard 2005
    1. Howard L, Hoffbrand SE, Henshaw C, Boath L, Bradley E. Antidepressant prevention of postnatal depression. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD004363.pub2] - DOI - PubMed
Huang 2013
    1. Huang HL, Chuang LT, Li HH, Lin CP, Glew R. Docosahexaenoic acid in maternal and neonatal plasma phospholipids and milk lipids of Taiwanese women in Kinmen: fatty acid composition of maternal blood, neonatal blood and breast milk. Lipids in Health and Disease 2013;12(27):1‐8. [DOI: 10.1186/1476-511X-12-27] - DOI - PMC - PubMed
Kendall‐Tackett 2007
    1. Kendall‐Tackett K, Duffy L, Zollo L, Geck L, Holmes A, Dodge J, et al. A Breastfeeding‐Friendly Approach to Depression in New Mothers A Curriculum and Resource Guide for Health Care Providers. The New Hampshire Breastfeeding Task Force Website: http://www.lllflorida.com/Web%20Leader/pp%20depression%20curriculum.pdf 2007. Accessed 26th March 2013.
Kendell 1987
    1. Kendell RE, Chalmers L, Platz C. The epidemiology of puerperal psychoses. British Journal of Psychiatry 1987;150:662‐73. - PubMed
Lobato 2011
    1. Lobato G, Moraes C, Dias A, Reichenheim M. Postpartum depression according to time frames and sub‐groups: a survey in primary health care settings in Rio de Janeiro, Brazil. Archives of Women's Mental Health 2011;14(3):187‐93. - PubMed
Marangell 2004
    1. Marangell LB, Martinez JM, Zboyan HA, Chong H, Puryear LJ. Omega‐3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open‐label pilot study. Depression Anxiety 2004;19:20‐3. - PubMed
Mayberry 1993
    1. Mayberry L, Affonso D. Infant temperament and postpartum depression: a review. Health Care for Women International 1993;14(2):204‐11. - PubMed
Miller 2002
    1. Miller LJ. Postpartum depression. JAMA 2002;287:762‐5. - PubMed
Mischoulon 2002
    1. Mischoulon D, Fava M. Role of S‐adenosyl‐L‐methionine in the treatment of depression: a review of the evidence. American Journal of Clinical Nutrition 2002;76(5):1158S–1161S. - PubMed
Miyake 2006
    1. Miyake Y, Sasaki S, Tanaka K, Yokoyama T, Ohya Y, Fukushima W, et al. Dietary folate and vitamins B12, B6, and B2 intake and the risk of postpartum depression in Japan: the Osaka Maternal and Child Health Study. Journal of Affective Disorders 2006;96(1‐2):133‐8. - PubMed
Montgomery 1979
    1. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382‐9. - PubMed
Murray 1992
    1. Murray L. The impact of postnatal depression on infant development. Journal of Child Psychology and Psychiatry 1992;33(3):543‐61. - PubMed
Murray 1996
    1. Murray L, Fiori‐Cowley A, Hooper R, Cooper P. The impact of postnatal depression and associated adversity on early mother‐infant interactions and later infant outcome. Child Development 1996;67(5):2512‐26. - PubMed
Murray 1999
    1. Murray L, Sinclair D, Cooper P, Ducournau P, Turner P, Stein A. The socioemotional development of 5‐year‐old children of postnatally depressed mothers. Journal of Child Psychology & Psychiatry & Allied Disciplines 1999;40(8):1259‐71. - PubMed
NHMRC 1999
    1. NHMRC. Postnatal depression: a systematic review of published scientific literature to 1999. Commonwealth of Australia 1999.
Nott 1987
    1. Nott P. Extent, timing and persistence of emotional disorders following childbirth. British Journal of Psychiatry 1987;151:523‐7. - PubMed
O'Hara 1996
    1. O'Hara M, Swain A. Rates and risk of postpartum depression ‐ a meta‐analysis. International Review of Psychiatry 1996;8(1):37‐54.
Oberlander 2004
    1. Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. Journal of Clilnical Psychiatry 2004;65(2):230‐7. - PubMed
Pedros‐Rosello 2007
    1. Pedros‐Rosello A. Postpartum depression and childrearing style on child development. In: Rosenfeld A editor(s). New Research on Postpartum Depression. New York: Nova, 2007:105‐30.
Pitt 1973
    1. Pitt B. Maternity blues. British Journal of Psychiatry 1973;122:431‐3. - PubMed
Rees 2005
    1. Rees AM, Austin MP, Parker G. Role of omega‐3 fatty acids as a treatment for depression in the perinatal period. Australian and New Zealand Journal of Psychiatry 2005;39(4):274‐80. - PubMed
RevMan 2011 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Shah 2009
    1. Shah P, Ohlsson A. Effects of prenatal multimicronutrient supplementation on pregnancy outcomes: a meta‐analysis. CMAJ 2009;180(12):E99‐E108. - PMC - PubMed
Simopoulos 2008
    1. Simopoulos P. The importance of the omega‐6/omega‐3 fatty acid ratio in cardiovascular disease and other chronic diseases. Experimental Biology and Medicine 2008;233(6):674‐88. - PubMed
Spitzer 1978
    1. Spitzer R, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry 1978;35:773‐82. - PubMed
Steiner 1990
    1. Steiner M. Postpartum psychiatric disorders. Canadian Journal of Psychiatry 1990;35(1):89‐95. - PubMed
Udechuku 2010
    1. Udechuku A, Nguyen T, Hill R, Szego K. Antidepressants in pregnancy: a systematic review. Australian and New Zealand Journal of Psychiatry 2010;44(11):978‐96. - PubMed
WHO/DIMDI 2006
    1. WHO & DIMDI (German Institute of Medical Documentation and Information). International Statistical Classification of Diseases and Related Health Problems 10th Revision Version for 2007. http://apps.who.int/classifications/apps/icd/icd10online/ (accessed 2009).
Wisner 2004
    1. Wisner K, Perel J, Peindl K, Hanusa B, Piontek C, Findling R. Prevention of postpartum depression: a pilot randomized clinical trial. American Journal of Psychiatry 2004;161(7):1260‐92. - PubMed
Wojcicki 2011
    1. Wojcicki JM, Hayman MB. Maternal omega‐3 fatty acid supplementation and risk for perinatal maternal depression. Journal of Maternal‐Fetal and Neonatal Medicine 2011;24(5):680‐6. - PMC - PubMed
Yehuda 1999
    1. Yehuda S, Rabinovitz S, Mostofsky DI. Essential fatty acids are mediators of brain biochemistry and cognitive functions. Journal of Neuroscience Research 1999;56(6):565‐70. - PubMed

Publication types

MeSH terms